Bandingkan Harga & Kinerja Jaya Konstruksi Manggala Pratama Tbk (JKON) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Jaya Konstruksi Manggala Pratama Tbk dan Organon Pharma Indonesia Tbk.: Jaya Konstruksi Manggala Pratama Tbk diperdagangkan di Rp85 (kapitalisasi pasar 1,42 T, volume 24 jam 13,59 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jaya Konstruksi Manggala Pratama Tbk jauh lebih besar — sekitar 13,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| JKON | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,42 T | 104,4 M |
Volume | 13,59 jt | — |
Lot | 135,93 rb | — |
Perputaran | 1,16 M | — |
Harga Rata-rata | 85,47 | — |
Nilai Transaksi | 1,16 M | — |
Harga Ekuilibrium Indikatif | 85 | — |
Volume Ekuilibrium Indikatif | 383 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Jaya Konstruksi Manggala Pratama Tbk
PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.
Selengkapnya di halaman JKON →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
